glycosyl
ubiquit
posttransl
modif
respons
multitud
crucial
biolog
role
oblig
parasit
virus
exploit
hostcel
machineri
glycosyl
protein
replic
viral
envelop
protein
varieti
human
pathogen
includ
influenza
viru
lassa
viru
sar
zika
viru
dengu
viru
ebola
viru
evolv
extens
glycosyl
hostcel
deriv
glycan
facilit
divers
structur
function
role
viral
lifecycl
rang
immun
evas
glycan
shield
enhanc
immun
cell
infect
review
highlight
imper
auxiliari
role
glycan
play
specif
oligosaccharid
structur
facilit
function
viral
pathogenesi
discuss
grow
effort
exploit
viral
glycobiolog
develop
antivir
vaccin
therapi
increas
emerg
infecti
diseas
particularli
caus
viral
infect
constitut
signific
threat
global
health
numer
envelop
viral
pathogen
evolv
take
advantag
hostcel
process
includ
glycosyl
pathway
decor
surfac
protein
self
glycan
moieti
analysi
viral
glycosyl
across
differ
famili
reveal
signific
variat
structur
densiti
conserv
glycan
understand
endogen
function
immunolog
basi
drive
viral
divers
promis
guid
develop
next
gener
vaccin
antivir
discuss
vari
role
glycosyl
play
viral
lifecycl
host
immun
respons
infect
viral
glycosyl
investig
context
number
envelop
glycoprotein
includ
envelop
glycoprotein
env
human
immunodefici
hemagglutinin
glycoprotein
ha
influenza
viru
coronaviru
glycoprotein
spike
glycoprotein
gp
ebola
viru
glycoprotein
complex
gpc
lassa
viru
envelop
e
glycoprotein
dengu
zika
flavivirus
howev
glycosyl
virus
limit
envelop
glycoprotein
mani
secret
viral
protein
present
glycan
necessari
respect
function
nonstructur
flavivirus
secret
gp
ebola
secret
glycoprotein
g
sgg
herp
simplex
viru
hsv
proteindisplay
glycosyl
fundament
wide
rang
molecular
cellular
process
divid
accord
intrins
extrins
function
intrins
function
base
upon
intramolecular
properti
glycoprotein
extrins
function
result
modul
intermolecular
interact
glycoprotein
glycanbind
partner
lectin
antibodi
sever
form
glycosyl
occur
natur
focu
intrins
extrins
function
nlink
mucintyp
olink
glycosyl
viral
pathogenesi
fig
nlink
glycosyl
occur
asparagin
residu
asnxserthr
sequon
x
amino
acid
except
prolin
viral
protein
glycosyl
hostcel
virus
abl
hijack
cellular
glycosyl
addit
glycan
genet
encod
glycosyl
signific
select
pressur
factor
immun
evas
function
glycoprotein
fold
assembl
initi
step
nlink
glycan
biosynthesi
involv
coval
en
bloc
attach
nlink
glycan
precursor
onto
asparagin
residu
nascent
polypeptid
chain
oligosaccharyltransferas
ost
earli
endoplasm
reticulum
er
point
process
enzym
trim
subsequ
build
glycan
result
potenti
vast
assort
differ
class
glycan
name
oligomannos
hybrid
complextyp
nglycan
structur
fig
import
note
context
virus
glycosyl
pathway
may
strictli
linear
evid
viral
particl
bud
earlytransloc
glycosyl
pathway
may
account
presenc
unusu
glycan
viral
glycoprotein
furthermor
known
mani
viral
glycoprotein
follow
classic
secret
pathway
exampl
traffic
directli
er
plasma
membran
bypass
glycan
matur
golgi
apparatu
particular
rout
exhibit
hepat
c
viru
yield
viral
popul
domin
oligomannosetyp
glycan
exist
nonclass
secret
rout
also
import
experiment
implic
exampl
env
glycoprotein
pseudovirus
exhibit
unusu
elev
level
oligomannosetyp
glycan
compar
infecti
viru
produc
peripher
blood
mononuclear
cell
like
due
deviat
away
nativelik
viru
bud
pathway
pseudovir
system
cellular
basi
effect
entir
clear
howev
known
viru
bud
compromis
nativ
membran
integr
variat
bud
rout
appar
experiment
system
like
viru
biolog
associ
glycosyl
heterogen
set
nativ
infect
mucintyp
olink
glycosyl
serin
threonin
tyrosin
residu
coval
link
galnac
residu
polypeptidenacetylgalactosaminetransferas
ppgalnact
form
call
tn
antigen
total
mucintyp
oglycan
core
common
core
structur
core
process
protein
pass
golgi
apparatu
fig
unlik
nlink
glycosyl
identifi
specif
amino
acid
sequon
simplic
identifi
olink
glycosyl
like
due
differenti
peptid
substrat
prefer
multipl
ppgalnact
howev
olink
glycosyl
mucinlik
domain
detect
high
level
serin
threonin
prolin
residu
recent
develop
improv
predict
individu
olink
glycosyl
site
nonmucinlik
domain
heterogen
occup
composit
olink
glycosyl
constitut
major
challeng
studi
glycan
structur
function
number
viral
protein
notabl
ebola
gp
sgp
herp
simplex
viru
gc
protein
respiratori
syncyti
viru
g
protein
contain
mucinlik
domain
high
popul
serin
threonin
residu
heavili
modifi
mucintyp
olink
glycan
whilst
known
virus
typic
utilis
nand
olink
hostcel
glycosyl
pathway
adorn
glycoprotein
carbohydr
modif
import
mention
known
except
notabl
exampl
virus
encod
enzym
involv
glycosyl
protein
macromolecul
chlorovirus
mimivirus
although
envelop
virus
rotavirus
also
exploit
hostglycosyl
pathway
modifi
protein
b
follow
mrna
synthesi
matur
triglucosyl
nlink
glycan
precursor
dolicholppglycan
cotransl
transfer
en
bloc
oligosaccharyltransferas
asparagin
residu
asnxserthr
sequon
nascent
polypeptid
chain
follow
transfer
precursor
glycan
protein
glucosidas
er
remov
three
glucos
residu
protein
fold
calnexincalreticulin
cycl
seri
er
golgi
mannosidas
subsequ
cleav
mannos
residu
man
glcnac
glycan
action
glcnac
transferasei
glcnacti
initi
first
branch
nglycan
ii
remov
two
remain
outer
mannos
residu
glycan
process
enzym
galactosyl
fucosyland
sialyltransferas
act
construct
huge
assort
complextyp
glycan
c
mucintyp
olink
glycosyl
pathway
initi
famili
ppgalnac
transferas
coval
link
nacetylgalactosamin
galnac
monosaccharid
serin
threonin
tyrosin
residu
follow
conjug
seri
glycosyltransferas
act
upon
primari
galnac
residu
gener
four
common
olink
glycan
core
core
extend
process
gener
numer
mucintyp
olink
glycan
glycan
present
use
consortium
function
glycom
symbol
nomenclatur
oxford
system
linkag
per
key
character
nand
olink
glycan
present
particular
analyt
challeng
due
extraordinari
heterogen
complex
aris
number
glycan
process
enzym
resid
er
golgi
apparatu
howev
coincid
advent
potent
mass
spectrometr
chromatograph
techniqu
commerci
avail
recombin
glycosidas
investig
posttransl
modif
becom
feasibl
advanc
enabl
experiment
approach
includ
matrix
assist
laser
desorpt
ionis
maldi
electrospray
ionis
esi
mass
spectrometri
allow
character
viral
glycom
ie
carbohydr
repertoir
specif
viral
protein
isol
present
pathogen
recent
augment
biophys
techniqu
name
inlin
liquid
chromatographi
mass
spectrometri
lcm
possibl
defin
exact
glycan
structur
present
individu
glycosyl
site
addit
investig
carbohydrateprotein
interact
aid
develop
glycan
microarray
capabl
screen
carbohydr
specif
glycanbind
protein
immobil
predefin
glycan
structur
furthermor
advanc
comput
biolog
sequenc
technolog
also
provid
crucial
insight
evolut
viral
glycosyl
bioinformat
approach
allow
greater
predict
understand
virus
evolv
utilis
glycosyl
given
particular
cell
exhibit
specif
portfolio
glycan
process
enzym
cellular
origin
viral
replic
potenti
significantli
influenc
viral
glycosyl
similarli
multicellular
target
host
display
rang
tissuespecif
glycosyl
potenti
influenc
viral
tropism
one
extrem
glycosyl
composit
differ
across
differ
speci
import
featur
interspeci
transmiss
potenti
inde
mani
human
pathogen
zoonot
virus
anim
reservoir
although
mammalian
nlink
glycan
pathway
larg
wellconserv
sever
key
differ
impact
viral
antigen
exampl
human
lack
epitop
common
structur
termin
mammalian
glycan
antibodybas
immun
epitop
limit
crossspeci
viral
infect
similarli
olink
glycan
glycolipid
exhibit
pronounc
composit
differ
across
speci
extrem
immunolog
effect
hostspecif
protein
lipid
glycosyl
also
influenc
spread
virus
within
speci
glycan
differ
evid
within
human
popul
abo
blood
group
system
peopl
blood
group
blood
group
b
express
fucosylglycoprotein
fucosylglycoprotein
galactosyltransferas
respect
presenc
antibodi
glycan
structur
foreign
blood
group
exampl
antia
present
blood
group
b
individu
limit
viral
transmiss
blood
group
b
blood
group
individu
effect
document
infect
virus
distribut
blood
group
may
select
pressur
shape
presenc
distribut
viral
underprocess
glycan
rare
present
matur
host
cell
glycoprotein
innat
immun
system
abl
recognis
glycan
pathogenassoci
molecular
pattern
pamp
use
solubl
lectin
h
glycan
antibodi
epitop
glycan
shield
conserv
viral
glycoprotein
possibl
humor
immun
respons
rare
case
elicit
neutralis
antibodi
target
sugar
part
epitop
spread
similarli
target
specif
blood
group
attach
factor
viral
bacteri
entri
may
also
influenc
preval
particular
viral
strain
base
frequenc
blood
group
within
popul
tissuespecif
glycosyl
also
key
determin
interspeci
viral
transmiss
potenti
lead
target
vulner
tissu
within
host
exampl
capac
avian
influenza
ha
interact
sialic
acid
shown
facilit
spillov
viru
bird
human
addit
differenti
express
sialic
acid
structur
upper
lower
respiratori
tract
human
shape
distribut
influenza
infect
within
individu
presenc
distribut
glycan
specif
cell
surfac
lectin
togeth
hostspecif
viral
glycosyl
also
influenc
transmiss
exampl
transmiss
insectborn
virus
mammal
founder
viru
display
featur
specif
invertebr
glycosyl
whilst
subsequ
virion
manufactur
new
host
contain
mammalian
glycosyl
thu
viral
glycosyl
undergo
composit
switch
upon
interspeci
transmiss
influenc
interact
immunolog
receptor
respons
also
influenc
viral
tropism
invertebr
display
chiefli
paucimannosid
structur
thu
insectborn
diseas
dengu
zika
structur
may
affect
lectinutilis
infect
tropism
depend
origin
viral
replic
overal
extrem
import
consid
cellular
biosynthet
origin
virus
natur
experiment
system
review
survey
widerang
factor
shape
presenc
process
viral
glycosyl
role
glycosyl
play
viral
pathogenesi
fig
one
crucial
role
protein
glycosyl
effect
glycoprotein
fold
structur
sort
traffick
stabil
glycan
structur
integr
protein
fold
exhibit
signific
glycanprotein
interact
stabilis
protein
exampl
increas
solubl
protein
interact
surfac
hydrophob
residu
addit
glycan
also
assist
glycoprotein
fold
mediat
chaperon
interact
biosynthesi
glycoprotein
matur
er
requir
stepwis
remov
two
termin
glucos
residu
nlink
glycan
precursor
er
ii
leav
monoglucosyl
precursor
er
chaperon
calnexin
calreticulin
bind
substrat
glycan
sequest
glycoprotein
er
protein
abl
properli
fold
correctli
fold
chaperon
releas
alphaglucosidas
ii
cleav
final
glucos
residu
glycoprotein
stage
properli
fold
process
export
golgi
apparatu
modif
convers
glycoprotein
incorrectli
assembl
reglucosyl
udpglucos
glycoprotein
glucosyltransferas
uggt
result
glycoprotein
chaperon
feedback
loop
act
qualiti
control
mechan
ensur
sole
correctli
fold
glycoprotein
exit
er
due
dual
effect
protein
fold
difficult
determin
contribut
singl
glycan
glycoprotein
fold
assembl
howev
comprehens
mutagenesi
studi
individu
nlink
glycosyl
site
knockout
sever
viral
glycoprotein
direct
biophys
analysi
glycanprotein
interact
demonstr
relianc
host
translat
machineri
correct
protein
fold
therebi
pathogenesi
exampl
import
nlink
glycosyl
env
protein
fold
stabil
investig
thoroughli
includ
studi
systemat
dissect
requir
nlink
glycosyl
site
highlight
integr
glycan
necessari
correct
incorpor
virion
lack
glycan
seemingli
caus
misfold
trimer
env
prevent
effici
secret
display
viral
surfac
highlight
crucial
role
specif
nlink
glycan
due
import
protein
fold
viral
protein
function
certain
sugar
mimet
name
iminosugar
investig
antivir
activ
iminosugar
nbutyldeoxynojirimycin
nbdnj
inhibit
er
activ
result
gener
unfold
nonfunct
viral
glycoprotein
fig
antivir
activ
iminosugar
test
divers
spectrum
virus
includ
influenza
virus
ebola
viru
arenavirus
flavivirus
varieti
iminosugar
compound
shown
potent
inhibit
releas
infecti
virion
particl
number
infect
cell
inhibit
dengu
pathogeni
compound
demonstr
import
glycosyl
dengu
glycoprotein
fold
virul
despit
promis
antivir
properti
iminosugar
yet
clinic
approv
antivir
indic
one
barrier
clinic
applic
concentr
requir
treat
viral
infect
appear
offtarget
effect
drug
imped
host
gut
glucosidas
lead
diarrhoea
abdomin
pain
howev
deriv
investig
may
increas
antivir
specif
per
nlink
glycosyl
olink
glycosyl
also
shown
crucial
effici
viral
particl
format
infect
case
possess
eight
structur
glycoprotein
featur
olink
glycosyl
viral
express
cell
line
display
truncat
tn
sialyl
tn
antigen
result
sever
reduc
viral
titr
whilst
exact
mechan
yet
elucid
conceiv
correct
process
elong
olink
glycosyl
integr
either
viral
glycoprotein
traffick
stabil
viral
particl
format
infect
nlink
glycosyl
glycoprotein
also
shown
play
signific
role
intracellular
traffick
fold
direct
reader
review
bagdonait
et
al
cover
glycosyl
herpesvirus
thoroughli
virus
exploit
glycosyl
pathway
modifi
protein
also
utilis
host
glycan
receptor
attach
factor
fig
howev
interact
imped
viral
bud
infect
cell
consequ
virus
evolv
carbohydratecleav
enzym
facilit
effici
viral
bud
releas
notabl
exampl
abil
neuraminidas
influenza
virus
cleav
sialic
acid
residu
host
cell
surfac
negat
abil
hemagglutinin
ha
bind
hostcel
receptor
sugar
viru
bud
cell
membran
ha
spike
continu
bind
virion
particl
sialic
acid
residu
cell
surfac
sialidas
activ
na
remov
termin
sugar
residu
addit
na
cleav
sialic
acid
residu
glycoprotein
viru
envelop
enhanc
infect
prevent
aggreg
viru
particl
furthermor
na
thought
act
upon
sialic
acid
residu
mucin
gain
access
epitheli
cell
potenti
play
secondari
role
aid
viru
entri
host
cell
addit
varieti
paramyxovirus
includ
mump
parainfluenza
newcastl
diseas
virus
possess
hemagglutininneuraminidas
hn
glycoprotein
bind
cleav
sialic
acid
residu
viral
glycoprotein
integr
facilit
host
cell
entri
egress
varieti
therapeut
develop
mimic
sugar
bind
rel
deep
sugar
bind
site
na
compar
ha
combat
influenza
viru
infect
nainhibitor
commonli
nacetylneuramin
acid
deriv
competit
inhibit
na
activ
addit
structurebas
develop
competit
inhibitor
glycan
bind
site
hn
glycoprotein
explor
beyond
role
na
viral
releas
viral
glycoprotein
emerg
focu
vaccin
develop
current
influenza
vaccin
poorli
display
na
epitop
produc
robust
antina
antibodi
whilst
infect
mani
nareact
b
cell
antibodi
produc
develop
recombin
influenza
vaccin
improv
display
influenza
na
may
provid
method
vaccin
optimis
improv
target
na
broader
protect
diverg
influenza
strain
circul
human
popul
shed
secret
viral
glycoprotein
constitut
import
stratagem
employ
virus
misdirect
humor
immun
respons
fig
either
occur
absorb
neutralis
antibodi
modul
immun
respons
target
nonneutralis
epitop
gp
gene
ebola
viru
contain
polyu
stutter
region
drive
transcript
frameshift
gener
three
glycoprotein
dimer
secret
gp
sgp
account
approxim
transcript
fulllength
membranebound
fusion
protein
gp
account
transcript
trace
level
small
solubl
gp
ssgp
whilst
function
ssgp
yet
unknown
sgp
secret
infect
cell
associ
viral
immun
evas
act
antibodi
decoy
ebola
sgp
found
antigen
subvert
immun
system
wherein
sgp
redirect
humor
immun
respons
target
epitop
share
fulllength
gp
studi
mohan
et
al
also
demonstr
sgp
also
subvert
host
immun
respons
mice
previous
immunis
ebola
gp
major
antigen
transcript
antibodi
isol
ebola
survivor
macaqu
direct
toward
sgp
rather
gp
importantli
antibodi
like
nonneutralis
neutralis
antibodi
elicit
gp
may
crossreact
absorb
abund
sgp
extent
mimicri
glycan
compon
gp
sgp
contribut
overal
antigen
mimicri
immun
decoy
function
unknown
howev
given
glycan
shown
contribut
epitop
format
sgpgp
congruenc
glycan
process
glycan
like
import
compon
function
shed
attach
glycoprotein
subunit
lassa
viru
also
observ
acut
lassa
fever
human
whilst
exact
function
shed
yet
elucid
propos
may
act
immunolog
decoy
manner
akin
ebola
sgp
case
lassa
viru
solubl
structur
conform
distinct
present
trimer
gpc
highlight
potenti
function
immun
decoy
sinc
shed
like
present
nonfunct
conform
therebi
elicit
nonneutralis
antibodi
conserv
substanti
structur
rearrang
isol
subunit
old
world
arenavirus
loei
river
morogoro
viru
may
highlight
conserv
mechan
immun
evas
amongst
pathogen
dengu
viru
nonstructur
intrigu
glycoprotein
secret
infect
cell
exhibit
two
nlink
glycosyl
site
shown
via
mutagenesi
studi
essenti
number
crucial
role
includ
hexam
format
facilit
secret
modul
protein
stabil
bind
heparin
sulphat
chondroitin
sulphat
glycosaminoglycan
surfac
variou
cell
shown
play
role
viral
replic
immun
evas
hypothesis
immun
recognit
endotheli
cell
surfac
may
facilit
vascular
leakag
sever
dengu
infect
use
secretedsh
gp
order
subvert
immun
system
andor
enhanc
infect
appear
common
phenomenon
utilis
virus
exampl
includ
secret
form
respiratori
syncyti
viru
g
glycoprotein
distract
antibodyimmun
respons
act
decoy
secret
solubl
glycoprotein
epsteinbarr
viru
interfer
macrophag
differenti
activ
mhc
class
iimedi
antigen
present
respect
unteth
monomer
subunit
env
also
aris
due
improp
process
spike
shed
viral
envelop
fragment
divert
humor
immun
respons
expos
immunodomin
protein
epitop
present
function
env
protein
therebi
elicit
undesir
nonneutralis
antibodi
infect
role
nonneutralis
epitop
subvert
host
immun
respons
away
neutralis
epitop
import
consider
vaccin
develop
stimul
develop
immunogen
close
mimic
nativ
state
viral
spike
number
virus
includ
influenza
lassa
coronavirus
ebola
evolv
shield
respect
envelop
glycoprotein
hostderiv
glycan
prevent
antibodi
recognit
underli
protein
surfac
import
nlink
glycosyl
envelop
protein
respect
immun
evas
observ
across
mani
virus
includ
hepat
c
hepat
b
hendra
newcastl
diseas
herp
simplex
viru
class
fusion
protein
exhibit
particularli
high
densiti
glycan
consist
role
shield
focu
glycan
shield
trimer
class
fusion
protein
influenza
coronaviru
lassa
ebola
nipah
virus
fig
one
best
characteris
glycan
shield
env
sole
glycoprotein
found
viru
surfac
matur
env
exist
trimer
noncoval
associ
heterodim
gener
furin
cleavag
polypeptid
precursor
receptor
bind
subunit
help
dictat
host
cell
tropism
facilit
attach
receptor
coreceptor
facilit
viral
host
cell
membran
fusion
upon
receptor
bind
extens
conform
chang
env
follow
env
present
glycan
per
monom
median
glycan
site
glycan
subunit
extent
posttransl
modif
combin
intrins
flexibl
trimer
env
constant
evolut
glycan
shield
render
env
immunolog
challeng
target
result
dens
glycosyl
viral
protein
surfac
lead
format
socal
intrins
trimer
associ
mannosepatch
imp
tamp
respect
aris
due
steric
block
glycanprocess
enzym
er
golgi
apparatu
neighbour
glycan
often
underprocess
glycan
weakli
immunogen
sinc
produc
hostprocess
pathway
therebi
limit
respons
deviat
glycosyl
astoundingli
case
conserv
underprocess
glycan
result
gener
broadli
neutralis
antibodi
bnab
actual
target
immunoquiesc
hostderiv
glycan
part
epitop
bnab
discov
becom
clear
recognis
viral
mannos
patch
also
evolv
recognis
complex
hybridtyp
glycan
howev
observ
bnab
develop
subset
patient
sever
year
underscor
fact
glycan
shield
evolv
sustain
immunolog
pressur
repres
extrem
challeng
immun
system
import
consider
vaccin
strategi
consider
antigen
evolut
enabl
persist
spread
influenza
viru
human
popul
surfac
glycoprotein
ha
exist
trimer
heterodim
synthesis
singl
polypeptid
subsequ
cleav
receptor
bind
domain
membranefus
mediat
subunit
host
cell
proteas
similarli
env
ha
class
viral
fusion
protein
fig
play
vital
role
viral
entri
bind
host
receptor
via
receptor
bind
site
rb
locat
main
focu
immun
respons
ha
evolv
highest
rate
compar
influenza
viral
protein
presenc
acquisit
nlink
glycosyl
site
ha
play
crucial
role
immun
evas
evolut
ha
glycan
shield
constitut
import
defens
mechan
mask
neutralis
epitop
possess
averag
nlink
glycosyl
site
per
protom
sinc
acquir
retain
twice
mani
site
current
strain
exhibit
approxim
png
per
protom
similarli
spanish
flu
temporari
departur
human
circul
strain
incorpor
nlink
glycan
site
per
protom
interestingli
season
accumul
glycan
mostcommonli
incorpor
globular
head
domain
region
variabl
major
antigen
site
lie
seemingli
due
prefer
neutralis
antibodi
target
rbsproxim
region
accret
nlink
glycan
occlud
antigen
site
ha
howev
affect
ha
bind
receptor
particularli
neighbour
rb
function
constraint
render
abl
complet
shield
glycan
inde
appear
maximum
number
nlink
glycosyl
site
allow
one
time
result
replac
nonconserv
glycosyl
site
altern
nlink
glycan
sequon
word
plateau
number
glycosyl
site
appear
deriv
balanc
function
immun
evas
despit
potenti
fit
cost
increas
glycosyl
site
presenc
shown
compens
fit
cost
associ
antibodi
escap
mutat
composit
although
total
number
glycan
present
significantli
less
env
glycosyl
analys
reveal
abund
oligomannosetyp
glycan
specif
site
indic
restrict
glycan
process
potenti
area
higher
glycan
densiti
shield
epitop
mask
glycosyl
also
observ
coronaviru
spike
protein
env
influenza
use
nlink
glycosyl
shield
conserv
sialic
acid
bind
site
respect
coronavirus
appear
also
occlud
receptor
bind
domain
utilis
nlink
glycan
protein
coronavirus
larg
glycoprotein
potenti
nlink
glycan
site
per
protom
glycan
analysi
perform
ritchi
et
al
sever
acut
respiratori
syndrom
sar
protein
reveal
signific
popul
oligomannosetyp
glycan
furthermor
composit
analysi
glycan
shield
alphaand
deltacoronavirus
express
drosophila
cell
also
display
wide
varieti
oligomannosetyp
glycan
addit
flytyp
paucimannosid
glycan
whilst
extrem
like
nlink
glycan
site
coronaviru
spike
incorpor
occlud
certain
epitop
remain
unclear
effect
glycan
shield
facilit
immun
evas
sinc
antibodi
target
protein
readili
elicit
sparsiti
glycan
shield
may
reflect
overal
oligomannosetyp
glycan
proport
low
compar
evas
strong
virus
influenza
lassa
indic
less
dens
glycosyl
across
surfac
permit
process
glycan
enzym
er
golgi
apparatu
allow
antibodi
target
protein
surfac
viral
glycoprotein
appear
glycan
surround
receptor
bind
site
neg
impact
function
suggest
slightli
limit
glycan
shield
coronavirus
may
result
necess
ensur
effici
receptor
bind
lassa
viru
highli
pathogen
arenaviru
caus
sever
haemorrhag
fever
human
arenavirus
gener
categoris
old
new
world
pathogen
base
geograph
genet
antigen
properti
old
new
world
arenaviru
gpc
extens
glycosyl
remark
conserv
glycosyl
sequon
arenavir
gpc
express
singl
polyprotein
precursor
proteolyt
process
display
trimer
tripartit
protom
protom
consist
receptorbind
domain
class
membran
fusion
domain
retain
myristoyl
stabl
signal
peptid
oftinadequ
antibodi
immun
respons
elicit
arenavirus
part
attribut
shield
wouldb
antigen
epitop
conserv
nlink
glycan
previous
report
composit
model
lassa
viru
glycan
shield
compris
approxim
glycoprotein
mass
reveal
extent
shield
across
gpc
consist
dens
cluster
oligomannosetyp
glycan
side
trimer
nlink
glycan
protect
vulner
region
gpc
includ
put
lysosomalassoci
membran
bind
site
region
surround
fusion
loop
evolutionari
analysi
lassa
viru
gpc
reveal
residu
elev
nonsynonym
synonym
substitut
dnd
ratio
colocalis
region
lassa
viru
gpc
lower
level
glycan
densiti
provid
rational
lassa
viru
glycan
shield
protect
protein
surfac
humor
antibodi
respons
host
addit
hypothes
old
world
loei
river
arenaviru
gpc
encod
two
addit
nlink
glycan
subunit
observ
old
world
arenavirus
may
contribut
expand
oligomannosetyp
glycan
cluster
lassa
viru
gpc
nevertheless
conserv
nlink
glycosyl
site
arenavir
gpc
seem
extrem
like
glycan
shield
protein
surfac
conserv
across
famili
facilit
immun
evas
ebola
viru
highli
virul
pathogen
capabl
caus
sever
haemorrhag
fever
human
ebola
viru
envelop
surfac
glycoprotein
gp
also
exhibit
dens
glycosyl
suggest
role
immun
evas
ebola
gp
initi
express
pregp
cleav
furin
two
subunit
associ
disulphid
bridg
heterodim
assembl
trimer
mediat
extens
intersubunit
interact
surfac
nascent
virion
form
matur
ebola
gp
sole
respons
receptor
attach
fusion
entri
target
cell
ebola
gp
present
approxim
nlink
glycosyl
sequon
extens
mucinlik
domain
per
protom
fig
nlink
glycosyl
extens
olink
glycosyl
mucinlik
domain
shown
neg
impact
immunogen
hide
immunogen
protein
epitop
interestingli
antibodi
elicit
call
glycan
cap
mucinlik
domain
ebola
gp
characteris
although
compar
antibodi
bind
epitop
class
gp
base
fusionloop
domain
neutralis
limit
hypothesis
variat
neutralis
potenti
within
glycan
cap
mucin
antibodi
may
due
heterogen
nand
olink
glycosyl
process
state
glycan
shield
paramyxovirus
nipah
viru
influenc
differ
protein
architectur
famili
fig
although
similar
theme
immun
evas
report
nipah
viru
deadli
emerg
paramyxoviru
enter
host
cell
use
two
envelop
glycoprotein
attach
g
protein
bind
cell
receptor
fusion
f
glycoprotein
subsequ
implement
membran
fusion
pmid
paramyxoviru
f
protein
unlik
class
fusion
protein
describ
particip
receptor
bind
exhibit
significantli
vari
protein
architectur
compar
class
fusion
protein
howev
share
similar
utilis
nlink
glycan
protect
humor
immun
respons
nipah
viru
f
protein
possess
png
per
protom
indic
presenc
extens
shield
occlud
much
protein
surfac
exemplifi
fig
lack
dens
glycan
shield
like
relat
fact
nlink
glycan
nipah
f
modul
effici
membran
fusion
viral
entri
nevertheless
carbohydr
moieti
shown
protect
virion
neutralis
antibodi
suggest
tradeoff
evolutionari
advantag
increas
protect
immun
system
effect
protein
function
surfacedisplay
protein
nipah
viru
g
protein
also
immunolog
pressur
nlink
glycan
g
protein
shown
play
role
shield
virion
antibodi
neutral
overal
immun
evas
glycan
shield
molecular
mimicri
exploit
host
glycosyl
pathway
common
featur
observ
viral
class
fusion
protein
one
import
consider
understand
potenti
vari
role
effici
glycan
shield
context
immun
evas
regardless
potenti
differ
widespread
use
glycosyl
tactic
thwart
respons
humoralimmun
system
underscor
vulner
protein
epitop
immun
pressur
virus
influenza
lassa
appear
evas
strong
pathogen
utilis
vari
mechan
chang
immunogen
epitop
present
respect
envelop
protein
howev
shield
protein
surfac
viral
glycoprotein
glycan
foolproof
lead
evolut
antiglycan
antibodi
recognit
host
immun
respons
innat
humor
oligomannosetyp
glycan
imped
facilit
viral
propag
one
hand
glycan
trigger
sterilis
innat
immun
respons
exampl
activ
complement
cascad
hand
virus
exploit
innat
immun
receptor
dendrit
cellspecif
nonintegrin
dcsign
facilit
andor
augment
infect
dcsign
possess
ctype
carbohydr
recognit
domain
crd
coordin
calcium
ion
primari
subsit
facilit
bind
oligomannosetyp
glycan
found
virus
fig
dcsign
bind
trimannos
structur
found
oligomannos
type
glycan
importantli
glycoform
bound
dcsign
specif
oligomannosetyp
glycan
confer
presenc
phenylalanin
side
chain
crd
act
steric
block
obstruct
glcnac
residu
nlink
glycan
core
core
mannos
residu
complextyp
glycan
attempt
bind
select
oligomannosetyp
glycan
ensur
dcsign
interact
predominantli
foreign
pathogen
due
rariti
oligomannosetyp
glycan
express
correctli
process
host
glycoprotein
rel
proand
antivir
effect
presenc
oligomannosetyp
glycan
specif
viral
pathogen
also
import
note
necess
glycan
hostcel
invas
factor
vari
greatli
whilst
wide
spectrum
virus
shown
interact
lectin
major
virus
exampl
arenavirus
influenza
hepat
c
coronavirus
recognis
host
lectin
immun
cell
utilis
lectin
oblig
receptor
howev
case
hiv
lectin
interact
shown
expand
enhanc
infect
rout
comprehens
tabl
referenc
virus
associ
lectin
interact
found
review
van
breedam
et
al
although
mani
virus
utilis
lectin
host
protein
infect
virus
use
lectin
oblig
receptor
alphavirus
phlebovirus
report
employ
dcsign
primari
receptor
recognis
oligomannosetyp
glycan
viral
surfac
glycosyl
analysi
envelop
glycoprotein
prototyp
alphaviru
semliki
forest
viru
sfv
reveal
nearexclus
oligomannosetyp
glycan
popul
attach
glycoprotein
complextyp
glycosyl
membraneproxim
fusion
protein
similarli
phlebovirus
phenuivirida
famili
rift
valley
fever
viru
member
bunyaviral
order
sever
fever
thrombocytopenia
syndrom
viru
sftsv
display
oligomannosetyp
glycan
requir
dcsign
depend
cellular
attach
entri
mammalian
dendrit
cell
although
exact
composit
glycan
site
gn
gc
glycoprotein
understood
shown
one
site
use
attach
glycom
studi
understand
posttransl
modif
gn
gc
glycoprotein
uukuniemi
viru
rel
rift
valley
fever
viru
reveal
signific
popul
oligomannosetyp
glycan
predominantli
gc
glycoprotein
uukuniemi
viru
howev
depend
dcsign
ctype
lectin
infect
across
phlebovirus
still
fulli
understood
especi
consid
posit
nlink
glycosyl
site
wellconserv
across
famili
dengu
viru
anoth
pathogen
utilis
macrophag
mannos
receptor
dcsign
put
receptor
infect
macrophag
dendrit
cell
respect
structur
data
use
cryoem
dengu
complex
crd
dcsign
reveal
bind
nlink
glycan
residu
two
neighbour
e
protein
singl
crd
bind
dcsign
crd
result
signific
conform
chang
suggest
dcsign
attach
receptor
mediat
initi
bind
prior
membran
fusion
trigger
phdepend
rearrang
nevertheless
dcsign
shown
indispens
dengu
infect
dendrit
cell
ctype
lectin
usag
flavivirus
limit
infect
mammal
west
nile
viru
dengu
appear
employ
ctype
lectin
aed
aegypti
call
mosquito
galactos
specif
lectin
mosgctl
ligand
promot
infect
invertebr
vector
import
question
remain
regard
flaviviru
e
protein
glycosyl
usag
lectin
receptor
viral
pathogeni
composit
variat
glycosyl
insect
mammalian
express
system
determin
variabl
interact
lectin
differ
stage
infect
dens
glycan
shield
lassa
viru
contribut
immunolog
resist
immun
system
lead
gener
specif
oligomannosetyp
glycan
cluster
across
side
gpc
spike
glycan
shown
play
advantag
role
viru
infect
human
dendrit
cell
via
dcsign
mediat
recognit
lassa
infect
macrophag
dendrit
cell
thought
crucial
viral
pathogenesi
viru
propag
cell
also
induc
activ
suggest
mechan
avoid
immun
surveil
thu
whilst
dcsign
may
primari
receptor
lassa
viru
oligomannosetyp
glycan
gpc
act
attach
factor
posit
influenc
infect
immun
cell
similar
phenomenon
observ
env
recognit
oligomannosetyp
glycan
dcsign
shown
augment
infect
cell
dcsignmedi
enhanc
infect
target
cell
via
transinfect
also
observ
across
virus
includ
sar
wide
rang
membraneassoci
lectin
besid
dcsign
mannos
receptor
hepat
asialoglycoprotein
receptor
liverlymph
node
sinusoid
endotheli
cell
ctype
lectin
siglec
macrophag
galgalnacspecif
ctype
lectin
implic
provir
effect
grow
bodi
research
indic
membraneassoci
lectin
bind
mani
virus
augment
infect
advantag
pathogenesi
whether
paradox
consequ
due
lectin
function
tackl
nonvir
pathogen
fungi
bacteria
would
seem
like
immun
cell
exhibit
lectin
b
collagencontain
ctype
lectin
mannos
bind
lectin
mbl
recognis
oligomannosetyp
glycan
via
carbohydr
recognit
domain
contain
calcium
ion
pink
respons
mediat
primari
interact
bind
sugar
pdb
id
c
membran
bound
ctype
lectin
receptor
dcsign
recognis
oligomannosetyp
glycan
via
ca
ion
initi
phagocytosi
pathogen
pdb
id
broadli
neutralis
antibodi
recognis
conserv
oligomannosetyp
glycan
env
use
extend
complementaritydetermin
region
cdr
loop
orang
penetr
glycan
shield
pdb
id
e
uniqu
antioligomannos
antibodi
featur
uniqu
domainexchang
architectur
heavi
chain
orang
opposit
fab
domain
swap
pdb
id
utilis
combat
viral
infect
use
downstream
function
antigen
present
promin
exampl
antivir
lectin
activ
includ
oligomannosetyp
glycan
recognit
env
langerin
ctype
lectin
express
langerhan
cell
result
viru
internalis
degrad
seem
feasibl
membranebound
lectin
constitut
import
part
innat
immun
respons
oligomannos
glycanbear
virus
perhap
also
aid
antigen
present
glycan
bind
properti
limit
host
protein
viral
protein
also
possess
glycanbind
properti
viral
glycoprotein
capabl
specif
recogn
distinct
glycan
motif
host
cell
surfac
therebi
mediat
viral
entri
infect
tropism
depend
viru
host
cell
glycan
act
primari
receptor
coreceptor
andor
attach
factor
perhap
wellcharacteris
exampl
hemagglutinin
influenza
virus
abil
ha
recognis
bind
specif
glycan
moieti
via
receptor
bind
site
led
regard
viral
lectin
bind
event
ha
glycan
receptor
lead
endocyt
internalis
virion
subsequ
phdepend
viralendosom
membran
fusion
infect
target
cell
remark
crossspeci
transmiss
determin
preferenti
bind
glycan
receptor
singl
chang
sialic
acid
linkag
penultim
galactos
residu
gal
primarili
express
bird
pig
gastrointestin
respiratori
tract
cell
gal
predomin
structur
found
human
upper
respiratori
epitheli
cell
sialic
acid
host
glycan
recognit
limit
influenza
virus
mani
pathogen
paramyxovirus
rotavirus
norovirus
polyomavirus
coronavirus
also
possess
glycoprotein
sialic
acid
bind
capabl
facilit
host
cell
entri
glycan
recognis
virus
sole
present
glycoprotein
glycan
epitop
also
found
glycolipid
compos
oligosaccharid
link
ceramid
lipid
molecul
wide
found
hostcel
surfac
furthermor
interact
glycolipid
viral
envelop
cellular
receptor
implic
contribut
viral
pathogenesi
exampl
sialyllactosecontain
glycolipid
viral
membran
bound
lectin
found
dendrit
cell
mediat
transinfect
cell
gpc
old
world
arenavirus
includ
import
human
pathogen
lymphocyt
choriomening
viru
lassa
viru
clade
c
new
world
arenavirus
also
utilis
specif
host
glycan
motif
mediat
infect
initi
host
cell
entri
mediat
gpcmediat
attach
unusu
omannosyl
class
glycan
compos
trisaccharid
core
xyloseglucuron
acid
repeat
present
cell
surfac
receptor
gpc
recognis
call
matriglycan
arenavirus
enter
endocyt
pathway
virion
internalis
endosom
compart
case
lassa
viru
associ
lower
ph
induc
conform
chang
gpc
lead
bind
lysosomalassoci
membran
protein
subsequ
dissoci
gpc
trigger
viral
envelopeendosom
host
membran
fusion
suggest
glycosyl
key
primari
bind
event
gpc
also
follow
step
arenaviru
viral
fusion
specif
sialyl
nlink
glycan
posit
human
demonstr
crucial
lassa
viru
gpc
recognit
case
glycosyl
specif
host
protein
critic
attach
mani
arenavirus
asid
specif
hostglycan
bind
capabl
viral
envelop
protein
broader
interact
host
glycosaminoglycan
gag
present
target
cell
surfac
virus
includ
hiv
herp
simplex
dengu
shown
occur
promot
viral
attach
independ
cognat
receptor
bind
contact
gag
often
constitut
initi
interact
viru
target
host
cell
case
herpesvirus
glycoprotein
c
gc
b
gb
known
initi
bind
gag
heparan
sulphat
hs
proteoglycan
consist
glucuron
acid
glca
glcnac
disaccharid
repeat
variou
sulphat
group
saccharid
residu
primari
interact
herp
simplex
hs
proteoglycan
critic
remov
hs
cell
surfac
use
hsdefici
mutant
cell
line
render
cell
resist
infect
herp
simplex
interact
gag
limit
hs
chondroitin
sulfat
anoth
gag
found
extracellular
matrix
compos
altern
repeat
galnac
glca
carbohydr
sulphat
group
reveal
effici
bound
herp
simplex
indic
multipl
bind
specif
sulphat
gag
interestingli
mucinlik
domain
gc
shown
modul
bind
gag
highlight
complex
interplay
viral
host
glycosyl
import
determin
viral
infect
presenc
oligomannosetyp
glycan
uncommon
featur
matur
secret
cellsurfac
host
glycoprotein
readili
trigger
host
innat
immun
system
pathogenassoci
molecular
pattern
pamp
recognis
varieti
solubl
lectin
exampl
surfact
protein
spa
spd
mannosebind
lectin
mbl
fig
mbl
trimer
solubl
ctype
lectin
collectin
famili
constitut
circul
bloodstream
protom
trimer
possess
ctermin
crd
coil
coil
neck
domain
collagenlik
domain
cysteinerich
ntermin
domain
mbl
specif
bind
equatori
group
termin
mannos
sugar
glcnac
residu
whilst
individu
crd
bind
rel
weak
k
approxim
mm
abil
collectin
form
multitrimer
oligom
significantli
enhanc
glycan
bind
affin
via
avid
effect
result
k
valu
nm
rang
mbl
bind
viral
glycoprotein
recruit
mannosebind
lectinassoci
serin
proteas
masp
trigger
lectin
pathway
complement
system
furthermor
collagenlik
domain
interact
collectin
receptor
found
phagocyt
immun
cell
promot
clearanc
pathogen
ficolin
anoth
member
collagen
solubl
lectin
famili
found
serum
specif
recogn
glcnac
moieti
lectin
contribut
toward
function
complement
system
vital
combat
virus
mbl
shown
recognis
nlink
glycan
dengu
marburg
viru
ebola
influenza
sar
coronaviru
neutral
mechan
includ
recruit
complement
promot
clearanc
block
viral
fusion
interf
dcsign
mediat
transinfect
addit
solubl
lectin
found
sera
spa
spd
share
basic
structur
collectin
recogn
oligomannosetyp
glycan
viral
particl
lung
mechan
spa
spd
activ
combat
influenza
viru
infect
whether
inhibit
hemagglutinin
activ
neuraminidas
activ
promot
opsonis
virion
alveolar
macrophag
investig
interestingli
gradual
addit
nlink
glycan
site
influenza
virus
thought
attenu
viral
pathogen
partli
due
increas
level
spd
mediat
clearanc
lung
respiratori
virus
includ
coronavirus
respiratori
syncyti
viru
shown
target
surfact
protein
galectin
class
small
solubl
call
stype
lectin
bind
galactos
galactosecontain
glycoconjug
unlik
ctype
lectin
glycan
bind
crd
independ
calcium
bind
shown
bind
envelop
fusion
glycoprotein
f
nipah
hendra
ha
influenza
virus
inhibit
membran
fusion
howev
also
shown
promot
hiv
infect
cell
crosslink
viru
host
cell
vari
proand
antivir
consequ
solubl
lectin
interact
highlight
divers
time
paradox
role
play
innat
immun
system
selfglycan
natur
poorli
immunogen
import
featur
glycan
shield
function
exampl
host
antibodi
respons
readili
recognis
glycan
compon
viral
glycoprotein
howev
context
phenomena
observ
two
characteris
exampl
dengu
reveal
vari
mechan
glycanbind
antibodi
aris
case
chronic
natur
infect
enabl
eventu
evolut
antibodi
capabl
recognis
conserv
glycan
featur
envelop
spike
wherea
dengu
viru
antibodi
isol
target
structur
integr
glycan
case
challeng
exploit
potenti
vulner
vaccin
design
precursor
bcell
exhibit
requir
glycan
specif
neg
select
subset
patient
infect
develop
broadli
neutralis
antibodi
capabl
recognis
glycan
structur
env
due
immens
genet
divers
across
mani
broadli
neutralis
antibodi
target
conserv
featur
across
envelop
spike
name
glycan
shield
mani
antibodi
characteris
target
region
dens
glycosyl
gener
mannos
patch
also
hybridtyp
triand
tetraantennari
complex
type
glycan
due
intrins
weak
immunogen
natur
hostcel
deriv
glycan
mani
antihiv
bnab
target
glycan
often
adopt
unusu
architectur
overcom
epitop
mask
exampl
bnab
display
long
heavi
chain
complementar
determin
loop
penetr
glycan
shield
make
proteinprotein
contact
fig
featur
uniqu
domainexchang
phenomenon
variabl
domain
two
heavi
chain
exchang
give
rise
compact
dual
fab
architectur
fig
sinc
numer
env
bnab
specif
recognis
area
glycan
shield
composit
conserv
glycan
env
signific
implic
immunogen
design
vaccin
candid
would
emul
nativ
glycosyl
infecti
virion
order
elicit
bnab
broadli
neutralis
antibodi
epitop
compris
glycan
also
characteris
dengu
viru
e
protein
specif
bnab
abl
crossneutralis
four
dengu
viru
serotyp
bind
conserv
socal
e
dimer
epitop
ede
dengu
e
protein
present
matur
virion
surfac
repeat
dimer
contain
ede
bridg
two
monomer
subunit
two
conserv
nlink
glycosyl
site
ede
antibodi
divid
two
subclass
call
requir
conserv
glycan
bind
utilis
sugar
stronger
bind
part
neutralis
epitop
beyond
fact
ede
antibodi
possess
broadli
neutralis
capabl
across
multipl
serotyp
glycanbind
antibodi
abl
also
bind
partial
immatur
viral
particl
well
fulli
matur
virion
use
immunogen
elicit
ede
antibodi
propos
altern
rout
nextgener
vaccin
due
broadli
neutralis
natur
import
consider
vaccin
effect
antibodydepend
enhanc
infect
due
crossreact
natur
antibodi
case
like
glycan
composit
immunogen
combat
dengu
viru
care
consid
especi
tri
elicit
antibodi
target
ede
abil
envelop
virus
hijack
host
cell
glycosyl
machineri
adorn
glycoprotein
hostderiv
glycan
vital
multipl
facet
viral
pathogenesi
recent
advanc
field
glycosyl
analysi
provid
greater
insight
role
glycan
play
protein
traffick
fold
viral
attach
immun
respons
infect
often
viral
glycoprotein
sole
antigen
express
viral
surfac
constitut
crucial
vaccin
target
sinc
antigen
mimicri
fundament
licens
vaccin
import
glycosyl
immunogen
repres
observ
viru
elicit
antibodi
epitop
occlud
viru
nonn
glycoform
undesir
moreov
glycosyl
immunogen
play
central
role
innat
immun
recognit
enhanc
humor
immun
understand
glycan
structur
mode
recognit
function
also
result
develop
sever
therapeut
combat
wide
array
deadli
pathogen
suggest
grow
understand
viral
glycobiolog
provid
opportun
ration
develop
novel
therapeut
vaccin
